US Stock MarketDetailed Quotes

NOTV Inotiv

Watchlist
  • 3.100
  • -0.010-0.32%
Close Mar 18 16:00 ET
  • 3.100
  • 0.0000.00%
Post 16:05 ET
104.99MMarket Cap-0.67P/E (TTM)

About Inotiv Company

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Company Profile

SymbolNOTV
Company NameInotiv
Listing DateNov 25, 1997
Issue Price8.00
Founded1974
CEOMr. Robert W. Leasure, Jr
MarketNASDAQ
Employees2075
Fiscal Year Ends09-30
Address2701 Kent Avenue
CityWest Lafayette
ProvinceIndiana
CountryUnited States of America
Zip Code47906-1382
Phone1-765-463-4527

Company Executives

  • Name
  • Position
  • Salary
  • Robert W. Leasure, Jr
  • Director, President and Chief Executive Officer
  • 1.66M
  • John Gregory Beattie
  • Chief Operating Officer
  • --
  • Beth A. Taylor
  • Senior Vice President, Finance and Chief Financial Officer
  • 483.71K
  • Dr. John E. Sagartz, D.V.M.,PhD
  • Director and Chief Strategy Officer
  • 474.75K
  • Andrea Castetter
  • General Counsel, Corporate Secretary and Chief Compliance Officer
  • --
  • Brennan Freeman
  • Vice President, Finance, Corporate Controller and Principal Accounting Officer
  • --
  • Dr. Adrian Hardy, PhD
  • Executive Vice President
  • --
  • Jeffrey Arthur Krupp
  • Senior Vice President, Human Resources
  • --
  • R. Matthew Neff
  • Non-Executive Chairman of the Board
  • 146.78K
  • David Landman
  • Independent Director
  • 114.28K
  • Dr. Nigel Brown, PhD
  • Independent Director
  • 121.78K
  • Michael J. Harrington
  • Independent Director
  • 89.42K
  • Terry Coelho
  • Independent Director
  • 155.42K

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Fed’s March rate decision nears: Market pivot ahead?
How will the Fed's rate decision impact short-term trends in U.S. stocks? How would you reposition your portfolio? Show More